Waldenstrom's Macroglobulinemia
What is Waldenstrom's Macroglobulinemia?
Waldenstrom's Macroglobulinemia is a rare type of blood cancer that begins in your white blood cells. It is a slow-growing cancer classified as a type of non-Hodgkin's lymphoma. The condition causes your bone marrow to produce too many abnormal white blood cells called lymphoplasmacytic cells.
These abnormal cells make large amounts of an unusual protein called IgM, also known as macroglobulin or M protein. This protein can build up in your blood and make it thicker than normal, a condition called hyperviscosity. When your blood becomes too thick, it has trouble flowing through small blood vessels to deliver oxygen and nutrients throughout your body.
Waldenstrom's Macroglobulinemia affects about 3 out of every 1 million people each year. It usually develops in adults over age 60. The condition is typically slow-growing and may not cause symptoms for years. Many people live with this condition for a long time with proper monitoring and treatment.
Symptoms
Many people with Waldenstrom's Macroglobulinemia have no symptoms when first diagnosed. When symptoms do appear, they often develop slowly over time. Common symptoms include:
- Fatigue and weakness that does not improve with rest
- Unexplained weight loss over several months
- Enlarged lymph nodes in the neck, armpits, or groin
- Swelling of the liver or spleen causing abdominal fullness
- Easy bruising or bleeding from the nose or gums
- Frequent infections due to weakened immune function
- Vision problems or headaches from thickened blood
- Numbness or tingling in the hands and feet
- Dizziness or confusion from reduced blood flow
- Night sweats that soak through clothing
Some people have no symptoms at all and discover the condition only through routine blood work. Others may experience only mild symptoms for many years before needing treatment.
Concerned about Waldenstrom's Macroglobulinemia? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The exact cause of Waldenstrom's Macroglobulinemia remains unknown. Researchers believe it starts when DNA changes occur in a white blood cell, causing it to grow out of control. These abnormal cells then multiply and crowd out healthy blood cells in your bone marrow. A specific gene mutation called MYD88 L265P is found in about 90% of people with this condition.
Several risk factors may increase your chances of developing this condition. Age is the strongest risk factor, with most cases occurring in people over 60. Men are slightly more likely to develop it than women. Having a family history of Waldenstrom's Macroglobulinemia or related blood disorders increases your risk. People of European descent have higher rates than other ethnic groups. Some people with a condition called monoclonal gammopathy of undetermined significance, or MGUS, may develop Waldenstrom's Macroglobulinemia over time. Exposure to certain chemicals or infections may play a role, but more research is needed.
How it's diagnosed
Waldenstrom's Macroglobulinemia is typically diagnosed through specialized blood and urine tests that look for abnormal proteins. Your doctor may order protein electrophoresis tests that separate different proteins in your blood to identify the abnormal IgM protein. Immunofixation tests can confirm the specific type of abnormal protein present. Free light chain tests measure components of antibodies that may be elevated. Serum viscosity tests measure how thick your blood has become. A complete blood count checks for low levels of healthy blood cells.
If blood tests suggest Waldenstrom's Macroglobulinemia, your doctor will likely recommend a bone marrow biopsy to confirm the diagnosis. This procedure removes a small sample of bone marrow to examine under a microscope for abnormal cells. Imaging tests like CT scans may check for enlarged lymph nodes or organs. These specialized tests are not part of routine health panels and require specific orders from your doctor. Talk to our doctor about testing options if you have symptoms or risk factors for this condition.
Treatment options
Treatment for Waldenstrom's Macroglobulinemia depends on your symptoms and how the condition affects your body. Many people with no symptoms simply need regular monitoring without immediate treatment. Treatment typically begins when symptoms develop or blood counts change significantly.
- Regular monitoring with blood tests every 3 to 6 months for those without symptoms
- Chemotherapy medications to slow the growth of abnormal cells
- Targeted therapy drugs that attack specific proteins in cancer cells
- Immunotherapy medications that help your immune system fight cancer cells
- Plasmapheresis to remove excess protein from thickened blood
- Stem cell transplant for younger patients with aggressive disease
- Supportive care including blood transfusions for anemia
- Infection prevention with antibiotics or immunoglobulin replacement
- Gentle exercise and good nutrition to maintain strength
- Stress reduction techniques like meditation or yoga
Work closely with a hematologist or oncologist who specializes in blood cancers. They will create a personalized treatment plan based on your specific situation and health goals.
Frequently asked questions
Both are blood cancers that produce abnormal proteins, but they differ in important ways. Waldenstrom's Macroglobulinemia produces IgM protein and rarely causes bone damage or kidney problems. Multiple myeloma typically produces IgG or IgA proteins and often damages bones and kidneys. Treatment approaches differ based on these distinctions.
There is currently no cure for Waldenstrom's Macroglobulinemia, but it is often manageable as a chronic condition. Many people live for 10 to 20 years or more with proper treatment. The slow-growing nature of this cancer means some people never need treatment. Research continues to develop new therapies that improve outcomes and quality of life.
Testing frequency depends on whether you are receiving treatment or simply being monitored. People without symptoms typically need blood work every 3 to 6 months to watch for disease progression. Those undergoing treatment may need monthly or even weekly testing to monitor response and side effects. Your doctor will create a testing schedule based on your individual situation.
Hyperviscosity syndrome occurs when excess IgM protein makes your blood flow like syrup instead of water. Thick blood struggles to move through small blood vessels in your eyes, brain, and extremities. This can cause vision problems, headaches, dizziness, and confusion. Plasmapheresis can quickly remove excess protein and restore normal blood flow when this occurs.
Many people with Waldenstrom's Macroglobulinemia do not need immediate treatment after diagnosis. Your doctor will use a watch and wait approach if you have no symptoms and stable blood counts. Treatment typically begins when you develop symptoms, blood counts drop significantly, or the disease shows signs of progression. Some people never need treatment at all.
While lifestyle changes cannot cure this condition, they can support your overall health during treatment. Eating a nutrient-dense diet helps maintain strength and supports immune function. Gentle exercise preserves muscle mass and reduces fatigue. Getting enough sleep and managing stress may improve your quality of life. Avoiding infections through good hygiene is especially important with this condition.
Monoclonal gammopathy of undetermined significance, or MGUS, is a condition where abnormal proteins appear in the blood without causing symptoms. About 1% to 2% of people with MGUS develop Waldenstrom's Macroglobulinemia each year. If you have MGUS, regular monitoring helps catch progression early. Not everyone with MGUS will develop cancer, but closer monitoring is recommended.
Genetic testing can identify specific mutations like MYD88 L265P that are present in most cases of this condition. These tests help confirm the diagnosis and may guide treatment decisions. Some newer targeted therapies work better in people with certain genetic mutations. Your doctor may order genetic testing on your bone marrow or blood samples if you are diagnosed.
The abnormal IgM protein can sometimes attack the protective coating around nerves, causing peripheral neuropathy. This leads to numbness, tingling, or pain in the hands and feet. The protein may also deposit in nerve tissue and cause damage. Treatment that reduces IgM levels often improves neuropathy symptoms over time.
There is an increased risk among family members, though most cases occur without a family history. Having a first-degree relative with this condition or a related blood disorder raises your risk by 3 to 4 times. Researchers are studying genetic factors that may contribute to familial clustering. If you have a family history, mention this to your doctor during health screenings.